EligibleTrials

Patients Pregnant Women With or Without Primary Antiphospholipid Antibody Syndrome

Recruiting · NCT05786235 · Observational (researchers observe without assigning treatment) · Lead sponsor: IRCCS San Raffaele

View the official record on ClinicalTrials.gov →
Hypertension

Interventions studied

Collection of epidemiological and anamnestic data and collection of biological material (peripheral blood)

What this trial is about

The purpose of the study is to evaluate the ability of placental angiogenesis markers to predict the risk of PE in pregnancy in women with primary APS. To construct reference intervals of placental angiogenesis markers specific to women affected by primary APS in pregnancy by measuring the levels of sFlt-1and PlGF in serum maternal serum and their sFlt-1/PlGF ratio during the trimesters of gestation (I TM, II TM and III TM). For this aim the study will involve recruiting two groups of subjects, one will be cases and one will be controls.

Who can take part

Age range
18 Years to 45 Years
Sex
Female
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.